Insulin-like growth factor-1 for the prevention or treatment of retinopathy of prematurity

Key Points

• This protocol aims to assess the effectiveness of insulin-like growth factor-1 in preventing or treating retinopathy of prematurity in premature infants.
• Systematic review of existing studies
• Comparison of treatment and control groups
• Analysis of treatment effectiveness and safety
• Potential positive impact on preventing retinopathy of prematurity
• Enhanced vision outcomes observed in some studies
• Further research needed to validate effectiveness

Abstract